Dr. Momen-Heravi received her DDS from Tehran University of Medical Sciences in 2009 and moved to the USA in 2011 to pursue fundamental science. She conducted several years of fundamental research at Harvard Medical School and University of Massachusetts Medical School, focusing on the role of miRNAs in the regulation of innate immunity and cellular cross-talk. This research resulted in a PhD in Molecular Biology in 2016. As a clinician scientist, she is involved in patient care and leads clinical and mechanistic fundamental research projects focusing on the role of innate immunity in head and neck cancer, and inflammation-related diseases such as periodontal disease and sepsis.